ImmuPharma PLC Capital Reinvestment Ratio

Latest as of December 2009: 0.00x

ImmuPharma PLC capital reinvestment ratio. ImmuPharma PLC (IMM) has a Capital Reinvestment Ratio of 0.00x as of December 2009, meaning it reinvests 0% of its operating cash flow (GBX11.96 Million) in capital expenditures (GBX3.60K). Check ImmuPharma PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

GBX11.96 Million
GBX

Capital Expenditures

GBX3.60K
GBX

Data as of

Dec 2009
Most recent filing

Capital Reinvestment Ratio of ImmuPharma PLC (2009–2009)

Capital reinvestment ratio of ImmuPharma PLC from 2009 to 2009. This chart tracks ImmuPharma PLC's Capital Reinvestment Ratio across 1 annual periods. Also explore IMM shareholders equity momentum to track the company's year-over-year net asset growth rate.

ImmuPharma PLC Capital Reinvestment Ratio by Year (2009–2009)

ImmuPharma PLC capital reinvestment ratio by year from 2009 to 2009. For the full cash flow conversion analysis, see IMM cash flow metrics.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
2009 0.00x GBX11.96 Million GBX4.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow